As shown in Fig 3A (see Fig S6A for gating strategy), myeloid cells were approximately twofold more abundant than lymphoid cells in day 13 (D13) tumor infiltrates, with the myeloid (CD11b+)/lymphoid (CD11b−) cell ratio evolving progressively towards an enrichment in lymphocytes after Pant administration. Here, ITGAM is linked to neoplasm.